Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: GlobeNewswire
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatment isn’t designed with them in mind. The survey found that 41% of those diagnosed with depression and/or anxiety and who are currently taking a mental health medication think it feels “one-size-fits-all" and 74% of those who are still finding a medication that works for them say that mental health treatment feels "one-size-fits-all.” Of those diagnosed with depression and/or anxiety, nearly two-thirds (67%) say their mental health is a daily struggle, and more than half (52%) feel the healthcare system treats them like part of an “assembly line” more than an individual. "People are used to personalization in all aspects of their lives. It’s time we put the ‘me’ back in mental health care,” said Dr. Crystal Nels
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire
- 3 Small-Cap Stocks We Think Twice About [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026GlobeNewswire
- Myriad Genetics (MYGN) was upgraded by TD Cowen to "hold".MarketBeat
MYGN
Earnings
- 2/23/26 - Beat
MYGN
Sec Filings
- 4/15/26 - Form 4
- 4/15/26 - Form 4
- 4/14/26 - Form ARS
- MYGN's page on the SEC website